Racke MK - Search Results

1

Genetic analysis of the exon 1 position 49 CD152 dimorphism in multiple sclerosis.

Stuart R, Lovett-Racke AE, Frohman EM, Hawker K, Racke MK. Stuart R, et al. Among authors: racke mk. J Neuroimmunol. 2007 Nov;191(1-2):45-50. doi: 10.1016/j.jneuroim.2007.09.008. Epub 2007 Oct 24. J Neuroimmunol. 2007. PMID: 17920697 Free PMC article. Review.

2

Receptor revision and atypical mutational characteristics in clonally expanded B cells from the cerebrospinal fluid of recently diagnosed multiple sclerosis patients.

Monson NL, Brezinschek HP, Brezinschek RI, Mobley A, Vaughan GK, Frohman EM, Racke MK, Lipsky PE. Monson NL, et al. Among authors: racke mk. J Neuroimmunol. 2005 Jan;158(1-2):170-81. doi: 10.1016/j.jneuroim.2004.04.022. J Neuroimmunol. 2005. PMID: 15589051

3

Multiple toll-like receptor agonists act as potent adjuvants in the induction of autoimmunity.

Hansen BS, Hussain RZ, Lovett-Racke AE, Thomas JA, Racke MK. Hansen BS, et al. Among authors: racke mk. J Neuroimmunol. 2006 Mar;172(1-2):94-103. doi: 10.1016/j.jneuroim.2005.11.006. Epub 2005 Dec 20. J Neuroimmunol. 2006. PMID: 16360885

4

Phenotypic characterization of autoreactive T cells in multiple sclerosis.

Ratts RB, Karandikar NJ, Hussain RZ, Choy J, Northrop SC, Lovett-Racke AE, Racke MK. Ratts RB, et al. Among authors: racke mk. J Neuroimmunol. 2006 Sep;178(1-2):100-10. doi: 10.1016/j.jneuroim.2006.06.010. Epub 2006 Aug 8. J Neuroimmunol. 2006. PMID: 16901549

5

Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis.

Cameron EM, Spencer S, Lazarini J, Harp CT, Ward ES, Burgoon M, Owens GP, Racke MK, Bennett JL, Frohman EM, Monson NL. Cameron EM, et al. Among authors: racke mk. J Neuroimmunol. 2009 Aug 18;213(1-2):123-30. doi: 10.1016/j.jneuroim.2009.05.014. Epub 2009 Jul 24. J Neuroimmunol. 2009. PMID: 19631394 Free PMC article.

6

miRNAs in multiple sclerosis: regulating the regulators.

Guerau-de-Arellano M, Lovett-Racke AE, Racke MK. Guerau-de-Arellano M, et al. Among authors: racke mk. J Neuroimmunol. 2010 Dec 15;229(1-2):3-4. doi: 10.1016/j.jneuroim.2010.08.025. J Neuroimmunol. 2010. PMID: 20888650 Free PMC article. No abstract available.

7

A unique antibody gene signature is prevalent in the central nervous system of patients with multiple sclerosis.

Ligocki AJ, Lovato L, Xiang D, Guidry P, Scheuermann RH, Willis SN, Almendinger S, Racke MK, Frohman EM, Hafler DA, O'Connor KC, Monson NL. Ligocki AJ, et al. Among authors: racke mk. J Neuroimmunol. 2010 Sep 14;226(1-2):192-3. doi: 10.1016/j.jneuroim.2010.06.016. Epub 2010 Jul 23. J Neuroimmunol. 2010. PMID: 20655601 Free PMC article.

8

Targeting T cell costimulation in autoimmune disease.

Stuart RW, Racke MK. Stuart RW, et al. Among authors: racke mk. Expert Opin Ther Targets. 2002 Jun;6(3):275-89. doi: 10.1517/14728222.6.3.275. Expert Opin Ther Targets. 2002. PMID: 12223069 Review.

9

Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosis.

Karandikar NJ, Crawford MP, Yan X, Ratts RB, Brenchley JM, Ambrozak DR, Lovett-Racke AE, Frohman EM, Stastny P, Douek DC, Koup RA, Racke MK. Karandikar NJ, et al. Among authors: racke mk. J Clin Invest. 2002 Mar;109(5):641-9. doi: 10.1172/JCI14380. J Clin Invest. 2002. PMID: 11877472 Free PMC article.

10

Retinoic acid promotes the development of Th2-like human myelin basic protein-reactive T cells.

Lovett-Racke AE, Racke MK. Lovett-Racke AE, et al. Among authors: racke mk. Cell Immunol. 2002 Jan;215(1):54-60. doi: 10.1016/s0008-8749(02)00013-8. Cell Immunol. 2002. PMID: 12142036

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

200 results

Search Page

Filters